Suppr
超能文献

The changing landscape of cancer cell therapies: clinical trials and real-world data.

作者信息

Saez-Ibañez Ana Rosa, Upadhaya Samik, Partridge Tanya, Winkelman Daniel, Correa Diego, Campbell Jay

出版信息

Nat Rev Drug Discov. 2024 Oct;23(10):736-737. doi: 10.1038/d41573-024-00094-4.

DOI:10.1038/d41573-024-00094-4

PMID:38822118

Abstract

摘要

相似文献

The changing landscape of cancer cell therapies: clinical trials and real-world data.

Nat Rev Drug Discov. 2024 Oct;23(10):736-737. doi: 10.1038/d41573-024-00094-4.

Cancer cell therapies: the clinical trial landscape.

Nat Rev Drug Discov. 2020 Sep;19(9):583-584. doi: 10.1038/d41573-020-00099-9.

The Landscape of Cell and Gene Therapies for Solid Tumors.

Cancer Cell. 2021 Jan 11;39(1):7-8. doi: 10.1016/j.ccell.2020.12.005.

Clinical development of cell therapies for cancer: The regulators' perspective.

Eur J Cancer. 2020 Oct;138:41-53. doi: 10.1016/j.ejca.2020.07.006. Epub 2020 Aug 21.

Second chapter.

Science. 2016 Sep 2;353(6303):983-985. doi: 10.1126/science.353.6303.983.

Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patients.

Cytotherapy. 2015 Dec;17(12):1667-74. doi: 10.1016/j.jcyt.2015.09.008.

The translation of cell-based therapies: clinical landscape and manufacturing challenges.

Regen Med. 2015;10(1):49-64. doi: 10.2217/rme.14.73.

The global landscape of cancer cell therapy.

Nat Rev Drug Discov. 2018 Jul;17(7):465-466. doi: 10.1038/nrd.2018.74. Epub 2018 May 25.

Mapping the cell therapy landscape: insights into clinical trials and regulatory advances in China.

J Hematol Oncol. 2024 Oct 14;17(1):96. doi: 10.1186/s13045-024-01616-8.

Cell therapies for Chagas disease.

Cytotherapy. 2017 Nov;19(11):1339-1349. doi: 10.1016/j.jcyt.2017.07.014. Epub 2017 Sep 5.

引用本文的文献

Nanotechnology for CAR T cells and tumour-infiltrating lymphocyte therapies.

Nat Nanotechnol. 2025 Sep 10. doi: 10.1038/s41565-025-02008-w.

All you need to know about equipment validation for sterility testing.

J Clin Microbiol. 2025 Sep 10;63(9):e0147724. doi: 10.1128/jcm.01477-24. Epub 2025 Aug 11.

Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy.

Acta Pharm Sin B. 2025 Jun;15(6):2845-2866. doi: 10.1016/j.apsb.2025.04.002. Epub 2025 Apr 4.

Targeting ion channels: innovative approaches to combat cancer drug resistance.

Theranostics. 2025 Jan 1;15(2):521-545. doi: 10.7150/thno.103384. eCollection 2025.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The changing landscape of cancer cell therapies: clinical trials and real-world data.

Nat Rev Drug Discov. 2024 Oct;23(10):736-737. doi: 10.1038/d41573-024-00094-4.

Cancer cell therapies: the clinical trial landscape.

Nat Rev Drug Discov. 2020 Sep;19(9):583-584. doi: 10.1038/d41573-020-00099-9.

The Landscape of Cell and Gene Therapies for Solid Tumors.

Cancer Cell. 2021 Jan 11;39(1):7-8. doi: 10.1016/j.ccell.2020.12.005.

Clinical development of cell therapies for cancer: The regulators' perspective.

Eur J Cancer. 2020 Oct;138:41-53. doi: 10.1016/j.ejca.2020.07.006. Epub 2020 Aug 21.

Second chapter.

Science. 2016 Sep 2;353(6303):983-985. doi: 10.1126/science.353.6303.983.

Challenges in the harmonization of immune monitoring studies and trial design for cell-based therapies in the context of hematopoietic cell transplantation for pediatric cancer patients.

Cytotherapy. 2015 Dec;17(12):1667-74. doi: 10.1016/j.jcyt.2015.09.008.

The translation of cell-based therapies: clinical landscape and manufacturing challenges.

Regen Med. 2015;10(1):49-64. doi: 10.2217/rme.14.73.

The global landscape of cancer cell therapy.

Nat Rev Drug Discov. 2018 Jul;17(7):465-466. doi: 10.1038/nrd.2018.74. Epub 2018 May 25.

Mapping the cell therapy landscape: insights into clinical trials and regulatory advances in China.

J Hematol Oncol. 2024 Oct 14;17(1):96. doi: 10.1186/s13045-024-01616-8.

Cell therapies for Chagas disease.

Cytotherapy. 2017 Nov;19(11):1339-1349. doi: 10.1016/j.jcyt.2017.07.014. Epub 2017 Sep 5.

引用本文的文献

Nanotechnology for CAR T cells and tumour-infiltrating lymphocyte therapies.

Nat Nanotechnol. 2025 Sep 10. doi: 10.1038/s41565-025-02008-w.

All you need to know about equipment validation for sterility testing.

J Clin Microbiol. 2025 Sep 10;63(9):e0147724. doi: 10.1128/jcm.01477-24. Epub 2025 Aug 11.

Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy.

Acta Pharm Sin B. 2025 Jun;15(6):2845-2866. doi: 10.1016/j.apsb.2025.04.002. Epub 2025 Apr 4.

Targeting ion channels: innovative approaches to combat cancer drug resistance.

Theranostics. 2025 Jan 1;15(2):521-545. doi: 10.7150/thno.103384. eCollection 2025.

Suppr超能文献

The changing landscape of cancer cell therapies: clinical trials and real-world data.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译